retatrutide clinical trials results weight loss trial data phase 3 Lilly's retatrutide delivers promising results in Phase 3 trial : r The most powerful – Retatrutide Results: 28.3% Weight Loss

10.1186/s12876-022-02178-0 [DOI] [PMC free article] [PubMed] [Google Scholar] 47.Chen H, Wu L, Wang M, Shao B, Ye L, Zhang Y, Cao Q

Among Medicare patients, 18% started with a GLP-1 while 24% used an SGLT2, reflecting the higher prevalence of cardiovascular conditions in seniors and the dual benefits SGLT2s provide in heart health

First, as adjuncts to standard care, selected strains or formulationssuch as Escherichia coli Nissle 1917, VSL#3, and certain multi-strain probioticsprovide additive or synergistic benefits, improving key outcomes including clinical response, endoscopic remission, and health-related quality of life (HRQoL

FOR PULMONARY ASPIRATION SOURCE: DailyMed